Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

KRT14 anticorps (C-Term) (CF®568)

L’anticorps Souris Monoclonal anti-KRT14 a été validé pour IF, FACS et IHC (f). Il convient pour détecter KRT14 dans des échantillons de Humain, Rat et Souris.
N° du produit ABIN6172564

Aperçu rapide pour KRT14 anticorps (C-Term) (CF®568) (ABIN6172564)

Antigène

Voir toutes KRT14 Anticorps
KRT14 (Keratin 14 (KRT14))

Reactivité

  • 120
  • 74
  • 60
  • 16
  • 6
  • 3
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
Humain, Rat, Souris

Hôte

  • 74
  • 50
  • 2
Souris

Clonalité

  • 65
  • 60
  • 1
Monoclonal

Conjugué

  • 75
  • 7
  • 6
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 2
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
Cet anticorp KRT14 est conjugé à/à la CF®568

Application

  • 53
  • 52
  • 42
  • 32
  • 30
  • 17
  • 14
  • 13
  • 13
  • 12
  • 11
  • 11
  • 7
  • 2
  • 2
  • 1
  • 1
Immunofluorescence (IF), Flow Cytometry (FACS), Immunohistochemistry (Formalin-fixed Sections) (IHC (f))

Clone

LL002
  • Épitope

    • 28
    • 15
    • 14
    • 10
    • 4
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 2
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    • 1
    C-Term

    Fonction

    Mouse Monoclonal anti-Cytokeratin 14 (LL002), CF568 Conjugate

    Attributs du produit

    Cytokeratin 14 (CK14) belongs to the type I (or A or acidic) subfamily of low molecular weight keratins and exists in combination with keratin 5 (type II or B or basic). CK14 is found in basal cells of squamous epithelia, some glandular epithelia, myoepithelium, and mesothelial cells. Anti-CK14 is useful in differentiating squamous cell carcinomas from poorly differentiated epithelial tumors. Anti-CK14 is one of the specific basal markers for distinguishing between basal and non-basal subtypes of breast carcinomas. Anti-CK14 is also a good marker for differentiation of intraductal from invasive salivary duct carcinoma by the positive staining of basal cells surrounding the in-situ neoplasm as well as for differentiation of benign prostate from prostate carcinoma. Furthermore, this antibody has been useful in separating oncocytic tumors of the kidney from its renal mimics, and in identifying metaplastic carcinomas of the breast. Primary antibodies are available purified, or with a selection of fluorescent CF® dyes and other labels. CF® dyes offer exceptional brightness and photostability. Note: Conjugates of blue fluorescent dyes like CF®405S and CF®405M are not recommended for detecting low abundance targets, because blue dyes have lower fluorescence and can give higher non-specific background than other dye colors.

    Immunogène

    A synthetic peptide of 15 amino acid from the C-terminus of human keratin 14.

    Isotype

    IgG3
  • Indications d'application

    Immunohistology formalin-fixed 0.5-1.0 μg/mL
    • Staining of formalin-fixed tissues requires boiling tissue sections in 10 mM citrate buffer,  pH 6.0, for 10-20 min followed by cooling at RT for 20 minutes
    • Immunofluorescence 0.5-1 μg/mL
    • Flow Cytometry 0.5-1 μg/million cells/0.1 mL
    • Optimal dilution for a specific application should be determined by user

    Commentaires

    A431 cells. Skin or Squamous cell carcinoma

    Restrictions

    For Research Use only
  • Format

    Liquid

    Concentration

    100 μg/mL

    Buffer

    PBS/0.1 % BSA/0.05 % azide

    Agent conservateur

    Sodium azide

    Précaution d'utilisation

    This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Conseil sur la manipulation

    Protect from light
  • Antigène

    KRT14 (Keratin 14 (KRT14))

    Autre désignation

    Cytokeratin 14

    Sujet

    CK-14, Dowling Meara, ebs3, ebs4, Epidermolysis Bullosa Simplex, k14, Keratin 14, Keratin Type I Cytoskeletal 14, Koebner, krt14, NFJ

    Poids moléculaire

    ~50 kDa

    ID gène

    3861, 6545380

    UniProt

    P02533
Vous êtes ici:
Chat with us!